Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?
- 1 December 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 115 (9) , 715-720
- https://doi.org/10.1016/j.amjmed.2003.08.025
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?BMJ, 2002
- Guidelines for the management of rheumatoid arthritis: 2002 UpdateArthritis & Rheumatism, 2002
- Validation of the Framingham Coronary Heart Disease Prediction ScoresJAMA, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A guideline for the treatment and prevention of NSAID-induced ulcersAmerican Journal of Gastroenterology, 1998
- Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory DrugsAnnals of Internal Medicine, 1995
- Variations in the Utilization of Coronary Angiography for Elderly Patients with an Acute Myocardial InfarctionPublished by Wolters Kluwer Health ,1995
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory DrugsAnnals of Internal Medicine, 1991
- A note on a general definition of the coefficient of determinationBiometrika, 1991